Ambulatory Infusion Centers & Infusion Pharmacy

Our ambulatory infusion centers and infusion pharmacy attorneys combine deep industry insight and legal understandings of both pharmacy and buy and bill models to advise clients on the complexities of infusion offerings in varied sites of care, including home infusion, ambulatory infusion centers, health system infusion centers, infusion management, and pharmacy infusion. Our attorneys draw upon on experience across all aspects of an infusion business to provide comprehensive and business savvy guidance to clients, including knowledge in supply chain and class of trade issues; payor contracting and billing models; the 340B program; provider licensure and supervision; facility licensure; corporate practice of medicine and associated corporate formation issues of professional corporations; home health licensure and issues related to contractual relationships with nursing agencies; relationships with referral sources, such as medical directors; and joint ventures and collaborations, including joint ventures with hospitals.

Our infusion team includes industry veterans who have experience as both in-house general counsel and outside counsel for national infusion pharmacies and pharmacy service providers. Our experience includes matters related to regulatory, corporate, compliance, billing, and contracting issues. We regularly provide guidance to pharmacies, private equity firms, ambulatory infusion suite companies, home infusion companies, and hospitals on topics related to infusion.

Our full-service ambulatory infusion centers and infusion pharmacy team counsels clients on a variety of infusion issues, including:

  • Site start-up considerations, such as
    • Corporate structure and the corporate practice of medicine
    • State-specific licensure considerations
    • Provider licensure and supervision requirements
  • Payor contracting
  • Drug supplier and drug manufacturer relationships and contracting
  • Medicare and Medicaid billing and reimbursement policies
  • Intra-company considerations related to drug acquisition, staffing, supervision and billing
  • Medical director relationships
  • Management arrangements and associated contracting
  • Mergers and acquisitions
  • Joint ventures and collaborations
  • Representation of the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible for the operational and strategic management of Chartwell to CarepathRx, a platform company formed by Nautic Partners that offers pharmacy solutions to patients undergoing complicated medication therapies. Nautic will manage the UPMC pharmacy moving forward. Terms of the transaction were not disclosed.

    We represented the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible...
    Read More
    Client Type: Private Company
  • Representation of OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care, in its sale to Amerita, Inc., a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. Terms of the transaction were not disclosed.

    We represented OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care,...
    Read More
    Client Type: Private Company
  • Representation of Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor of home infusion services. Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry

    We represented Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor...
    Read More
    Client Type: Private Company
  • Representation of BioMatrix Specialty Pharmacy, a comprehensive, nationwide specialty pharmacy services and digital health technology solutions provider, in its acquisition of City Drugs, a New York City-based specialty pharmacy that specializes in the treatment of complex medical conditions including hepatitis, oncology, auto-immune diseases, and gastroenterology. Terms of the transaction were not disclosed.

    We represented BioMatrix Specialty Pharmacy, a comprehensive, nationwide specialty pharmacy services and digital health technology solutions provider, in its acquisition...
    Read More
    Client Type: Private Company
  • Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners

    We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
    Read More
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Read More
    Client Type: Public Company
  • Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC

    We represented Consonance Capital Partners, a leading healthcare-focused private equity fund, in the recapitalization of Orsini Pharmaceutical Services, LLC, in...
    Read More
    Client Type: Private Company
  • Represented Modern HC Holdings, Inc. in its sale to The Kroger Company

    Bass, Berry & Sims represented Modern HC Holdings, Inc., a specialty pharmacy focused on patients with chronic illnesses, in its...
    Read More
    Client Type: Private Company
  • Represented ModernHC Pharmacy in its acquisition of Infusion Therapy of Texas

    We represented ModernHC Pharmacy in its acquisition of Infusion Therapy of Texas, a regional home infusion pharmacy. ModernHC Pharmacy is...
    Read More
    Client Type: Private Company
  • Represented Diplomat Pharmacy, Inc. in its acquisition of BioRx, LLC for $350 million

    We represented Diplomat Pharmacy, Inc. in its acquisition of BioRx, LLC for $350 million in cash and stock. BioRx is...
    Read More
    Client Type: Public Company
Zachary  J. Baumann
Associate
Jeffrey I. Davis
Member
K. Stewart Day
Associate
Jeanne Marie Evans
Associate
Mary Beth Fortugno
Member
Maleaka N. Guice
Associate
Michael R. Hess
Member
Dante G. Lizza
Associate
Whitney Mosey
Associate
Frank M. Pellegrino
Member
Shannon Wiley
Member

Past Events